14 Years: #ProstateCancer & Active Surveillance | Bill Manning, Director of @aspi2020

14 Years: #ProstateCancer & Active Surveillance | Bill Manning, Director of @aspi2020
Share:

Download MP3


Similar Tracks

Testing and Monitoring #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI Prostate Cancer Research Institute
A Discussion on Nutrition & #ProstateCancer With Nutrition Expert Verne Varona & #AlexScholz Prostate Cancer Research Institute
Active Surveillance of Prostate Cancer Stanford Health Care
Focal Therapy For #ProstateCancer | Answering Your Questions | #MarkScholzmd #AlexScholz #PCRI Prostate Cancer Research Institute
3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRI Prostate Cancer Research Institute
Understanding Prostate Biopsy Results | #MarkScholzMD #AlexScholz #PCRI Prostate Cancer Research Institute
Think Twice Before a Prostate Biopsy: The Evidence You Need to Hear Intellectual Medicine
Seminal Vesicle Invasion #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI Prostate Cancer Research Institute
Your Gleason Score Matters | #ProstateCancer #MarkScholzMD #AlexScholz Prostate Cancer Research Institute
Managing an Elevated PSA: Avoiding Unnecessary Prostate Biopsies Intellectual Medicine
What Every Man MUST KNOW To PREVENT Prostate Cancer | Dr. Ted Schaeffer x Rich Roll Rich Roll
Navigating #ProstateCancer: Expert Tips on Choosing the Best Prostate Cancer Care | #MarkScholzMD Prostate Cancer Research Institute
What's New in Active Surveillance for Prostate Cancer Memorial Sloan Kettering Cancer Center
A future with No Prostate Biopsies with Mark Emberton, MD EP 86 Dr. Geo Prostate Podcast
Active Surveillance & #ProstateCancer In 2024 | Laurence Klotz, MD #PCRI #2024PCRICon Prostate Cancer Research Institute
Active Surveillance for Low Risk Prostate Cancer by Lawrence Klotz Focal Therapy Society
Advanced #ProstateCancer Treatments + Extended Q+A | #MarkScholzMD & #MarkMoyadMD #PCRI Prostate Cancer Research Institute
Why Early Treatment of Prostate Cancer May Be Ineffective: The Case for Conventional Therapies Intellectual Medicine
Active Surveillance for prostate cancer – the past, present, and future ASPI: Active Surveillance Patients International
Gleason 3+4 Prostate Cancer Royal Berkshire NHS Foundation Trust